Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000412219 | SCV000578336 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Ambry Genetics | RCV000131979 | SCV000187037 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000159875 | SCV000209942 | benign | not specified | 2014-07-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000197285 | SCV000253499 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000412219 | SCV000489222 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2016-09-06 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000131979 | SCV000683050 | likely benign | Hereditary cancer-predisposing syndrome | 2015-09-03 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000412219 | SCV001280879 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001284390 | SCV001470162 | likely benign | not provided | 2023-01-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000412219 | SCV004815669 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000159875 | SCV005090351 | likely benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV001284390 | SCV001906247 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001284390 | SCV001951043 | likely benign | not provided | no assertion criteria provided | clinical testing |